Literature DB >> 11005823

Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase.

S I Liochev1, I Fridovich.   

Abstract

The copper- and zinc-containing superoxide dismutase can catalyze the oxidation of ferrocyanide by O(2) as well as the reduction of ferricyanide by O(2). Thus, it can act as a superoxide dismutase (SOD), a superoxide reductase (SOR), and a superoxide oxidase (SOO). The human manganese-containing SOD does not exert SOR or SOO activities with ferrocyanide or ferricyanide as the redox partners. It is possible that some biological reductants can take the place of ferrocyanide and can also interact with human manganese-containing superoxide dismutase, thus making the SOR activity a reality for both SODs. The consequences of this possibility vis à vis H(2)O(2) production, the overproduction of SODs, and the role of copper- and zinc-containing superoxide dismutase mutations in causing familial amyotrophic lateral sclerosis are discussed, as well as the likelihood that the biologically effective SOD mimics, as described to date, actually function as SORs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005823     DOI: 10.1074/jbc.M007891200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

Review 2.  4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.

Authors:  Marzia Perluigi; Raffaella Coccia; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2012-02-15       Impact factor: 8.401

3.  Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.

Authors:  Wycliffe O Opii; Gururaj Joshi; Elizabeth Head; N William Milgram; Bruce A Muggenburg; Jon B Klein; William M Pierce; Carl W Cotman; D Allan Butterfield
Journal:  Neurobiol Aging       Date:  2006-10-20       Impact factor: 4.673

Review 4.  Activation of superoxide dismutases: putting the metal to the pedal.

Authors:  Valeria Cizewski Culotta; Mei Yang; Thomas V O'Halloran
Journal:  Biochim Biophys Acta       Date:  2006-05-17

Review 5.  Mathematical and computational models of oxidative and nitrosative stress.

Authors:  Mahendra Kavdia
Journal:  Crit Rev Biomed Eng       Date:  2011

6.  Superoxide release from contracting skeletal muscle in pulmonary TNF-α overexpression mice.

Authors:  Li Zuo; Allison H Hallman; William J Roberts; Peter D Wagner; Michael C Hogan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-11-06       Impact factor: 3.619

Review 7.  Genetics of amyotrophic lateral sclerosis.

Authors:  Nailah Siddique; Teepu Siddique
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

8.  Effect of alcohol exposure on hepatic superoxide generation and hepcidin expression.

Authors:  Duygu Dee Harrison-Findik; Sizhao Lu; Emily M Zmijewski; Jocelyn Jones; Matthew C Zimmerman
Journal:  World J Biol Chem       Date:  2013-11-26

9.  Evaluating associations between early pregnancy trace elements mixture and 2nd trimester gestational glucose levels: A comparison of three statistical approaches.

Authors:  Yinnan Zheng; Cuilin Zhang; Marc G Weisskopf; Paige L Williams; Birgit Claus Henn; Patrick J Parsons; Christopher D Palmer; Germaine M Buck Louis; Tamarra James-Todd
Journal:  Int J Hyg Environ Health       Date:  2019-12-28       Impact factor: 5.840

10.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.